...
首页> 外文期刊>Saudi Pharmaceutical Journal >Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
【24h】

Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin

机译:设计疏水性槲皮素的聚合物微粒递药系统

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the model drug quercetin through ionic cross linking method. In vitro drug release, swelling index, drug entrapment efficiency, Fourier Transforms Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calorimetric (DSC) studies were also done for physicochemical characterization of the formulations. Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formulation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal confirming the prevention of drug release in the acidic environment of stomach. Comparatively more sustained release was seen from the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7h of drug release profiling. Drug entrapment efficiency of the formulations shows in F1 (D:C:A=2:5:30) was approximately 70% whereas the increase in chitosan concentration in F2 (D:C:A=2:10:30) has shown an entrapment efficiency of 81%. But the comparative further increase of chitosan concentration in F3 (D:C:A=2:15:30) has shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR analysis of drug, polymers and the formulations indicated the compatibility of the drug with the polymers. The smoothness of microspheres in F2 & F3 was confirmed by Scanning Electron Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively. The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution profile, formulated microparticles can help us to obtain amorphous form of the same drug that is likely to have more dissolution property. The findings of the study suggest that the microsphere formulations were a promising carrier for quercetin delivery and can be considered as a favorable oral controlled release dosage form for hydrophobic drug quercetin.
机译:这项研究的目的是研究聚合的​​微颗粒药物传递系统的药物潜力,以调节水溶性差的槲皮素的药物特性。在这项研究工作中,使用了两种具有成本效益的聚合物海藻酸钠和壳聚糖通过离子交联方法截留模型药物槲皮素。还进行了体外药物释放,溶胀指数,药物截留效率,傅立叶变换红外光谱(FTIR),扫描电子显微镜(SEM),X射线衍射(XRD)和差示扫描量热法(DSC)研究,以对药物进行理化表征。配方。在pH为1.2、6.8和7.4的条件下进行了溶胀指数和药物释放研究,以评估GI模拟作用,这意味着所有配方1(F1),配方2(F2)和配方3(F3)在pH值下均会溶胀和释放最低限度地证实了在胃的酸性环境中1.2的药物释放的预防。在药物释放曲线分析7h后,在pH 6.8和pH 7.4的配方F2和F3中观察到相对更持续的释放。 F1(D:C:A = 2:5:30)中制剂的药物截留效率约为70%,而F2(D:C:A = 2:10:3​​0)中壳聚糖浓度的增加显示出包封率达81%。但是,F3中壳聚糖浓度的进一步增加(D:C:A = 2:15:30)显示出80%的截留率,与F2没有明显差异。药物,聚合物和配方的FTIR分析表明药物与聚合物具有相容性。 F2和F3中微球的光滑度通过扫描电子显微镜(SEM)确认。然而,F1微球相对显示出更多的不规则形状。 DSC研究表明在微球中不存在药物-聚合物相互作用。我们的XRD研究表明,当纯药物显示出具有较少溶出度的晶体结构时,配制的微粒可以帮助我们获得可能具有更多溶出性的相同药物的无定形形式。研究结果表明,微球制剂是槲皮素递送的有希望的载体,并且可以被认为是疏水性槲皮素的有利的口服控释剂型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号